NM_001136139.4:c.1663G>A
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PS3PM2PP3_ModeratePP5_Very_Strong
The NM_001136139.4(TCF3):c.1663G>A(p.Glu555Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/18 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV004020919: This variant was reported in the literature as the missense change p.E555K from the alternate transcript encoding the E47 isoform. This variant was reported in five unrelated heterozygous individuals affected with Agammaglobulinaemia and failure of B-cell development (Boisson_2013, Al_Sheikh_2021), and parental testing suggested this was a de novo mutation in all of the patients. These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function for the p.E555K missense change in cells that were transfected with a vector to produce the mutated E47 protein. This demonstrated that the mutant E47 localizes to the nucleus normally but shows substantially reduced binding to the E5 immunoglobulin enhancer probe in vitro compared to the wildtype protein, and exerts a strong dominant negative effect when binding to the probe as a homodimer with wildtype E47 (Boisson_2013). PMID:24216514" and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. E555E) has been classified as Likely benign.
Frequency
Consequence
NM_001136139.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal agammaglobulinemiaInheritance: AD, SD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- agammaglobulinemia 8, autosomal dominantInheritance: AD, AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
- agammaglobulinemia 8b, autosomal recessiveInheritance: AR Classification: MODERATE Submitted by: PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001136139.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TCF3 | MANE Plus Clinical | c.1663G>A | p.Glu555Lys | missense | Exon 18 of 20 | NP_001129611.1 | P15923-2 | ||
| TCF3 | MANE Select | c.1823-508G>A | intron | N/A | NP_003191.1 | P15923-1 | |||
| TCF3 | c.1663G>A | p.Glu555Lys | missense | Exon 18 of 19 | NP_001338708.1 | P15923-2 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TCF3 | TSL:2 MANE Plus Clinical | c.1663G>A | p.Glu555Lys | missense | Exon 18 of 20 | ENSP00000468487.1 | P15923-2 | ||
| TCF3 | TSL:1 MANE Select | c.1823-508G>A | intron | N/A | ENSP00000262965.5 | P15923-1 | |||
| TCF3 | TSL:1 | n.1181-508G>A | intron | N/A |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1461592Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727082
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at